首页> 外文学位 >Part I. Cytochrome c oxidase active-site modeling: Synthesis and characterization of new unsymmetrical tris(imidazole- and pyridine-appended) picket-fence porphyrins and their metal complexes. Part II. Toward fullerene-based radiopharmaceuticals: High-yield neutron activation of endohedral holmium-165 metallofullerenes.
【24h】

Part I. Cytochrome c oxidase active-site modeling: Synthesis and characterization of new unsymmetrical tris(imidazole- and pyridine-appended) picket-fence porphyrins and their metal complexes. Part II. Toward fullerene-based radiopharmaceuticals: High-yield neutron activation of endohedral holmium-165 metallofullerenes.

机译:第一部分:细胞色素c氧化酶活性位点建模:新的不对称三(咪唑和吡啶附加)栅栏卟啉及其金属配合物的合成与表征。第二部分迈向基于富勒烯的放射性药物:内含165金属富勒烯的高产中子活化。

获取原文
获取原文并翻译 | 示例

摘要

Part I. Two new unsymmetrical picket-fence porphyrin ligands 1 and 2 and their metal complexes have been prepared as potentially improved structural models for the binuclear (Fe/Cu) Cytochrome c Oxidase (CcO) active site. 1 and 2 have a naphthyl porphyrin superstructure which has been specifically designed to confer long-term configurational stability and allow synthetic manipulations to be easily performed without fear of atropisomer interconversions. The compounds also incorporate a covalently-linked, axially-offset tris(heterocycle) coordination site for a copper ion, like that found in the native CcO enzyme. Monometallic complexes [M = Zn(II), Ni(II), Cu(II), Fe(III)] of the imidazole- and pyridine-appended porphyrin ligands have been prepared and fully characterized. Only the Fe(III) hydroxide porphyrin complex reacted further with Cu(II) salts to form a heterobinuclear species of as yet unestablished structure. The unexpected difficulty of forming binuclear species is attributed to the conformational flexibility of the OCH2 spacer in 1 and 2, which presumably does not encourage a favorable chelation conformation to be assumed.; Part II. Endohedral holmium metallofullerenes, 165Hox C82/84 (x = 1,2), have been prepared by carbon-arc methods and separated from empty fullerenes by HPLC techniques. The 165Ho metallofullerenes and empty C60 were then bombarded with neutrons under differing flux conditions to understand the various modes of compound degradation and to maximize yields of activated 166Hox C82/84 [165Ho(n,gamma) 166No]. C60 survived irradiation to a fairly high extent (>80%) at total neutron doses of 1018 n cm--2 (75% thermal neutrons), but fast-neutron damage progressed rapidly thereafter, leaving only a few percent of surviving material. Under identical flux conditions, the metallofullerenes were degraded much more quickly and extensively (10% survival) than was C60. Furthermore, decomposition of the metal lofullerenes was shown to proceed primarily by fast-neutron damage instead of the predicted (n,gamma)-metal-atom recoil. Higher percentage thermal-neutron fluxes (96% and 99.7%) gave significantly improved metallofullerene survival (20---30% at total doses of 1015--10 16 n cm--2), and degradation under these conditions was demonstrated to proceed exclusively through the anticipated metal-recoil pathway. The present study establishes the general feasibility of developing radiopharmaceuticals based on neutron-activated endohedral metallofullerene materials.
机译:第一部分。准备了两个新的不对称栅栏卟啉配体1和2及其金属配合物,作为双核(Fe / Cu)细胞色素c氧化酶(CcO)活性位点的潜在改进结构模型。图1和图2具有萘基卟啉的上层结构,该上层结构经过特别设计以赋予长期的构型稳定性,并使合成操作易于进行,而不必担心阻转异构体相互转化。这些化合物还结合了铜离子的共价连接的,轴向偏移的三(杂环)配位点,就像在天然CcO酶中发现的那样。已制备并充分表征了咪唑和吡啶附加的卟啉配体的单金属配合物[M = Zn(II),Ni(II),Cu(II),Fe(III)]。仅氢氧化铁(III)卟啉配合物进一步与铜(II)盐反应,形成结构尚未确定的异双核物质。形成双核物种的意外困难归因于OCH2间隔基在1和2中的构象柔韧性,这大概不会促进假定的有利螯合构象。第二部分内己ral金属富勒烯165Hox C82 / 84(x = 1,2)已通过碳弧法制备,并通过HPLC技术与空的富勒烯分离。然后在不同的通量条件下用中子轰击165Ho金属富勒烯和空C60,以了解化合物降解的各种方式并最大化活化166Hox C82 / 84 [165Ho(n,γ)166No]的产率。 C60在总中子剂量<1018 n cm--2(75%热中子)的照射下在相当高的程度上幸存(> 80%),但是此后快速中子损坏迅速发展,仅留下了百分之几的幸存物质。在相同的通量条件下,金属富勒烯的降解比C60更快,更广泛(存活率<10%)。此外,金属富勒烯的分解主要通过快中子破坏而不是预测的(n,γ)-金属原子反冲来进行。更高的热中子通量百分比(96%和99.7%)显着提高了金属富勒烯的存活率(总剂量为1015--10 16 n cm--2时为20 --- 30%),并且证明了在这些条件下降解的进行仅通过预期的金属反冲路径。本研究建立了开发基于中子活化的内面金属富勒烯材料的放射性药物的一般可行性。

著录项

  • 作者

    Thrash, Thomas Pennix.;

  • 作者单位

    Rice University.;

  • 授予单位 Rice University.;
  • 学科 Chemistry Inorganic.; Chemistry Nuclear.; Health Sciences Pharmacology.; Health Sciences Medicine and Surgery.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 275 p.
  • 总页数 275
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 无机化学;无机化学;药理学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号